Resistance characteristics of influenza to amino-adamantyls
- PMID: 20599692
- DOI: 10.1016/j.bbamem.2010.06.018
Resistance characteristics of influenza to amino-adamantyls
Abstract
The recent outbreaks of avian flu in Southeast Asia and swine flu in Mexico City painfully exemplify the ability of the influenza virus to rapidly mutate and develop resistance to modern medicines. This review seeks to detail the molecular mechanism by which the influenza virus has obtained resistance to amino-adamantyls, one of only two classes of drugs that combat the flu. Amino-adamantyls target the viral M2 H(+) channel and have become largely ineffective due to mutations in the transmembrane domain of the protein. Herein we describe these resistance rendering mutations and the compounded effects they have upon the protein's function and resulting virus viability.
2010 Elsevier B.V. All rights reserved.
Similar articles
-
Flu channel drug resistance: a tale of two sites.Protein Cell. 2010 Mar;1(3):246-58. doi: 10.1007/s13238-010-0025-y. Epub 2010 Feb 23. Protein Cell. 2010. PMID: 21203971 Free PMC article. Review.
-
Designing inhibitors of M2 proton channel against H1N1 swine influenza virus.PLoS One. 2010 Feb 23;5(2):e9388. doi: 10.1371/journal.pone.0009388. PLoS One. 2010. PMID: 20186344 Free PMC article.
-
How do aminoadamantanes block the influenza M2 channel, and how does resistance develop?J Am Chem Soc. 2011 Jun 29;133(25):9903-11. doi: 10.1021/ja202288m. Epub 2011 May 16. J Am Chem Soc. 2011. PMID: 21534619
-
Adamantane resistance among influenza A viruses isolated early during the 2005-2006 influenza season in the United States.JAMA. 2006 Feb 22;295(8):891-4. doi: 10.1001/jama.295.8.joc60020. Epub 2006 Feb 2. JAMA. 2006. PMID: 16456087
-
Viral M2 ion channel protein: a promising target for anti-influenza drug discovery.Mini Rev Med Chem. 2014;14(10):819-30. Mini Rev Med Chem. 2014. PMID: 25342196 Review.
Cited by
-
Profiling the in vitro drug-resistance mechanism of influenza A viruses towards the AM2-S31N proton channel blockers.Antiviral Res. 2018 May;153:10-22. doi: 10.1016/j.antiviral.2018.03.002. Epub 2018 Mar 6. Antiviral Res. 2018. PMID: 29518414 Free PMC article.
-
An infectious bat-derived chimeric influenza virus harbouring the entry machinery of an influenza A virus.Nat Commun. 2014 Jul 23;5:4448. doi: 10.1038/ncomms5448. Nat Commun. 2014. PMID: 25055345 Free PMC article.
-
A bacteria-based search for drugs against avian and swine flu yields a potent and resistance-resilient channel blocker.Proc Natl Acad Sci U S A. 2025 Aug 5;122(31):e2502240122. doi: 10.1073/pnas.2502240122. Epub 2025 Aug 1. Proc Natl Acad Sci U S A. 2025. PMID: 40748960 Free PMC article.
-
Emergence and evolution of avian H5N2 influenza viruses in chickens in Taiwan.J Virol. 2014 May;88(10):5677-86. doi: 10.1128/JVI.00139-14. Epub 2014 Mar 12. J Virol. 2014. PMID: 24623422 Free PMC article.
-
Molecular biophysics and inhibition mechanism of influenza virus A M2 viroporin by adamantane-based drugs - Challenges in designing antiviral agents.J Struct Biol X. 2025 Feb 4;11:100122. doi: 10.1016/j.yjsbx.2025.100122. eCollection 2025 Jun. J Struct Biol X. 2025. PMID: 40060197 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical